Franklin Friedman
Director/Board Member at DECIPHERA PHARMACEUTICALS, INC.
Net worth: 141 800 $ as of 30/04/2024
Franklin Friedman active positions
Companies | Position | Start | End |
---|---|---|---|
DECIPHERA PHARMACEUTICALS, INC. | Director/Board Member | 01/11/2019 | - |
Independent Dir/Board Member | 01/11/2019 | - | |
IPFS Corp.
IPFS Corp. Insurance Brokers/ServicesFinance IPFS Corp. engages in the provision of insurance brokerage services. The company was founded by Tom Charbonneau in 1977 and is headquartered in Kansas City, MO. | Chief Executive Officer | 01/01/2019 | - |
President | 01/01/2019 | - | |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Director/Board Member | 01/11/2019 | - |
Career history of Franklin Friedman
Former positions of Franklin Friedman
Companies | Position | Start | End |
---|---|---|---|
Deloitte LLP (New York)
Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY. | Chief Executive Officer | 01/01/2014 | 01/01/2015 |
Chief Operating Officer | 01/06/2015 | 01/11/2019 | |
Director of Finance/CFO | 01/06/2011 | 01/05/2016 | |
Deloitte Touche Tohmatsu Ltd.
Deloitte Touche Tohmatsu Ltd. Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu Ltd. provides auditing, financial advisory, tax, and consulting services. Its serves technology, consumer business, energy and resources, financial services, life sciences and health care, manufacturing, public sector, real estate, technology, media, and telecommunications industries. The company was founded in 1880 and is headquartered in New York, NY. | Chief Executive Officer | 01/01/2014 | 01/01/2015 |
Chief Operating Officer | 01/06/2015 | 01/11/2019 | |
Director of Finance/CFO | 01/06/2011 | 01/01/2015 |
Training of Franklin Friedman
University of Kansas | Undergraduate Degree |
Statistics
International
United States | 7 |
Operational
Chief Executive Officer | 3 |
Chief Operating Officer | 2 |
Director of Finance/CFO | 2 |
Sectoral
Commercial Services | 3 |
Health Technology | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
Private companies | 4 |
---|---|
IPFS Corp.
IPFS Corp. Insurance Brokers/ServicesFinance IPFS Corp. engages in the provision of insurance brokerage services. The company was founded by Tom Charbonneau in 1977 and is headquartered in Kansas City, MO. | Finance |
Deloitte LLP (New York)
Deloitte LLP (New York) Miscellaneous Commercial ServicesCommercial Services Deloitte LLP (New York) engages in the provision of audit, consulting, tax, and advisory solutions. It offers services relating to tax, consulting, audit and assurance, Deloitte private company services, mergers and acquisitions, risk and financial advisory, analytics, and cloud. The company was founded by William Welch Deloitte, George A. Touche, Charles Waldo Haskins, and Elijah Watt Sells in 1845 and is headquartered in New York, NY. | Commercial Services |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
Deloitte Touche Tohmatsu Ltd.
Deloitte Touche Tohmatsu Ltd. Miscellaneous Commercial ServicesCommercial Services Deloitte Touche Tohmatsu Ltd. provides auditing, financial advisory, tax, and consulting services. Its serves technology, consumer business, energy and resources, financial services, life sciences and health care, manufacturing, public sector, real estate, technology, media, and telecommunications industries. The company was founded in 1880 and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Franklin Friedman
- Experience